Literature DB >> 12121317

Determinants of ictal epileptiform patterns in the hippocampal slice.

Paul A Rutecki1, Umit Sayin, Yili Yang, Eldad Hadar.   

Abstract

PURPOSE: The transition from an interictal to an ictal pattern of epileptiform activity is a strategic target for antiepileptic drug (AED) action. Both the muscarinic agonist pilocarpine and the selective group I metabotropic glutamate receptor (mGluR) agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) produce prolonged synchronous activity in the hippocampal slice that resembles ictal discharges. We evaluated the role of synaptic mechanisms and release of calcium from intracellular stores in the generation of prolonged ictal oscillations.
METHODS: Pilocarpine (10 microM) in 7.5 mM[K+]o or DHPG (100 microM) in 5 mM[K+]o artificial cerebrospinal fluid (ACSF) were bath applied to hippocampal slices, and extracellular recordings were made from the CA3 region. The pattern of activity was characterized as ictal if prolonged oscillations of discharges occurred at >2 Hz lasting for >3 s. The pattern of epileptiform activity was characterized and compared with the pattern observed after bath application of pharmacologic agents.
RESULTS: The AMPA/kainic acid (KA) glutamate receptor blocker DNQX (20 microM) dampened and stopped ictal oscillations; however, antagonism of N-methyl-d-aspartate (NMDA) or gamma-aminobutyric acid (GABAA) receptors had minimal effects on ictal patterns. Ictal discharges were suppressed by dantrolene (30-100 microM), which blocks release of calcium from intracellular stores, or thapsigargin (1-5 microM), which inhibits the adenosine triphosphatase (ATPase) that maintains intracellular calcium stores. The L-type calcium channel antagonist nifedipine (1 microM) blocked ictal activity produced by pilocarpine or DHPG.
CONCLUSIONS: Ictal discharges produced by pilocarpine or DHPG depended on intact synaptic transmission mediated by AMPA/KA receptors, release of calcium from intracellular stores, and L-type calcium channel activation. The results suggest that muscarinic and group I mGluRs activate a positive-feedback system that creates calcium oscillations and prolonged neuronal synchronization mediated by recurrent excitatory synaptic connections in the CA3 region of the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121317     DOI: 10.1046/j.1528-1157.43.s.5.34.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Metabotropic glutamate receptors regulate hippocampal CA1 pyramidal neuron excitability via Ca²⁺ wave-dependent activation of SK and TRPC channels.

Authors:  Lynda El-Hassar; Anna M Hagenston; Lisa Bertetto D'Angelo; Mark F Yeckel
Journal:  J Physiol       Date:  2011-05-16       Impact factor: 5.182

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Authors:  J P Apland; V Aroniadou-Anderjaska; M F M Braga
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

Review 4.  Brain tumors and epilepsy: pathophysiology of peritumoral changes.

Authors:  Mohammed F Shamji; Elana C Fric-Shamji; Brien G Benoit
Journal:  Neurosurg Rev       Date:  2009-02-11       Impact factor: 3.042

5.  Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.

Authors:  Brita Fritsch; Jeffrey J Stott; Joy Joelle Donofrio; Michael A Rogawski
Journal:  Epilepsia       Date:  2009-07-20       Impact factor: 5.864

6.  NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus.

Authors:  Pradeep Punnakkal; Deity Dominic
Journal:  Neuromolecular Med       Date:  2018-01-15       Impact factor: 3.843

7.  Transition between fast and slow gamma modes in rat hippocampus area CA1 in vitro is modulated by slow CA3 gamma oscillations.

Authors:  Alexander N J Pietersen; Peter D Ward; Nicholas Hagger-Vaughan; James Wiggins; John G R Jefferys; Martin Vreugdenhil
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

Review 8.  Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit.

Authors:  Susanne Muehlschlegel; John R Sims
Journal:  Neurocrit Care       Date:  2008-08-12       Impact factor: 3.532

Review 9.  Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species.

Authors:  Stjepana Kovac; Albena T Dinkova Kostova; Alexander M Herrmann; Nico Melzer; Sven G Meuth; Ali Gorji
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.